163 related articles for article (PubMed ID: 34862398)
21. Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate.
Sun W; Leist SR; McCroskery S; Liu Y; Slamanig S; Oliva J; Amanat F; Schäfer A; Dinnon KH; García-Sastre A; Krammer F; Baric RS; Palese P
bioRxiv; 2020 Jul; ():. PubMed ID: 32743571
[TBL] [Abstract][Full Text] [Related]
22. Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease.
van der Lubbe JEM; Rosendahl Huber SK; Vijayan A; Dekking L; van Huizen E; Vreugdenhil J; Choi Y; Baert MRM; Feddes-de Boer K; Izquierdo Gil A; van Heerden M; Dalebout TJ; Myeni SK; Kikkert M; Snijder EJ; de Waal L; Stittelaar KJ; Tolboom JTBM; Serroyen J; Muchene L; van der Fits L; Rutten L; Langedijk JPM; Barouch DH; Schuitemaker H; Zahn RC; Wegmann F
NPJ Vaccines; 2021 Mar; 6(1):39. PubMed ID: 33741993
[TBL] [Abstract][Full Text] [Related]
23. Impact of an autophagy-inducing peptide on immunogenicity and protection efficacy of an adenovirus-vectored SARS-CoV-2 vaccine.
Sayedahmed EE; Araújo MV; Silva-Pereira TT; Chothe SK; Elkashif A; Alhashimi M; Wang WC; Santos AP; Nair MS; Gontu A; Nissly R; Francisco de Souza Filho A; Tavares MS; Ayupe MC; Salgado CL; Donizetti de Oliveira Candido É; Leal Oliveira DB; Durigon EL; Heinemann MB; Morais da Fonseca D; Jagannath C; Sá Guimarães AM; Kuchipudi SV; Mittal SK
Mol Ther Methods Clin Dev; 2023 Sep; 30():194-207. PubMed ID: 37502665
[TBL] [Abstract][Full Text] [Related]
24. MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans.
Mayer L; Weskamm LM; Fathi A; Kono M; Heidepriem J; Krähling V; Mellinghoff SC; Ly ML; Friedrich M; Hardtke S; Borregaard S; Hesterkamp T; Loeffler FF; Volz A; Sutter G; Becker S; Dahlke C; Addo MM
NPJ Vaccines; 2024 Jan; 9(1):20. PubMed ID: 38278816
[TBL] [Abstract][Full Text] [Related]
25. Full efficacy and long-term immunogenicity induced by the SARS-CoV-2 vaccine candidate MVA-CoV2-S in mice.
Lázaro-Frías A; Pérez P; Zamora C; Sánchez-Cordón PJ; Guzmán M; Luczkowiak J; Delgado R; Casasnovas JM; Esteban M; García-Arriaza J
NPJ Vaccines; 2022 Feb; 7(1):17. PubMed ID: 35140227
[TBL] [Abstract][Full Text] [Related]
26. A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters.
Bricker TL; Darling TL; Hassan AO; Harastani HH; Soung A; Jiang X; Dai YN; Zhao H; Adams LJ; Holtzman MJ; Bailey AL; Case JB; Fremont DH; Klein R; Diamond MS; Boon ACM
Cell Rep; 2021 Jul; 36(3):109400. PubMed ID: 34245672
[TBL] [Abstract][Full Text] [Related]
27. Synthetic Multiantigen MVA Vaccine COH04S1 Protects Against SARS-CoV-2 in Syrian Hamsters and Non-Human Primates.
Chiuppesi F; Nguyen VH; Park Y; Contreras H; Karpinski V; Faircloth K; Nguyen J; Kha M; Johnson D; Martinez J; Iniguez A; Zhou Q; Kaltcheva T; Frankel P; Kar S; Sharma A; Andersen H; Lewis MG; Shostak Y; Wussow F; Diamond DJ
bioRxiv; 2021 Sep; ():. PubMed ID: 34545366
[TBL] [Abstract][Full Text] [Related]
28. A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19.
Malherbe DC; Kurup D; Wirblich C; Ronk AJ; Mire C; Kuzmina N; Shaik N; Periasamy S; Hyde MA; Williams JM; Shi PY; Schnell MJ; Bukreyev A
NPJ Vaccines; 2021 Jul; 6(1):91. PubMed ID: 34294728
[TBL] [Abstract][Full Text] [Related]
29. Immunogenicity and efficacy of XBB.1.5 rS vaccine against EG.5.1 variant of SARS-CoV-2 in Syrian hamsters.
Boon J; Soudani N; Bricker T; Darling T; Seehra K; Patel N; Guebre-Xabier M; Smith G; Suthar M; Ellebedy A; Davis-Gardner M
Res Sq; 2024 Feb; ():. PubMed ID: 38405749
[TBL] [Abstract][Full Text] [Related]
30. A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge.
Yahalom-Ronen Y; Tamir H; Melamed S; Politi B; Shifman O; Achdout H; Vitner EB; Israeli O; Milrot E; Stein D; Cohen-Gihon I; Lazar S; Gutman H; Glinert I; Cherry L; Vagima Y; Lazar S; Weiss S; Ben-Shmuel A; Avraham R; Puni R; Lupu E; Bar-David E; Sittner A; Erez N; Zichel R; Mamroud E; Mazor O; Levy H; Laskar O; Yitzhaki S; Shapira SC; Zvi A; Beth-Din A; Paran N; Israely T
Nat Commun; 2020 Dec; 11(1):6402. PubMed ID: 33328475
[TBL] [Abstract][Full Text] [Related]
31. CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge.
Lien CE; Lin YJ; Chen C; Lian WC; Kuo TY; Campbell JD; Traquina P; Lin MY; Liu LT; Chuang YS; Ko HY; Liao CC; Chen YH; Jan JT; Ma HH; Sun CP; Lin YS; Wu PY; Wang YC; Tao MH; Lin YL
Sci Rep; 2021 Apr; 11(1):8761. PubMed ID: 33888840
[TBL] [Abstract][Full Text] [Related]
32. Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates.
Chiuppesi F; Nguyen VH; Park Y; Contreras H; Karpinski V; Faircloth K; Nguyen J; Kha M; Johnson D; Martinez J; Iniguez A; Zhou Q; Kaltcheva T; Frankel P; Kar S; Sharma A; Andersen H; Lewis MG; Shostak Y; Wussow F; Diamond DJ
NPJ Vaccines; 2022 Jan; 7(1):7. PubMed ID: 35064109
[TBL] [Abstract][Full Text] [Related]
33. Oral Administration of Universal Bacterium-Vectored Nucleocapsid-Expressing COVID-19 Vaccine is Efficacious in Hamsters.
Jia Q; Bielefeldt-Ohmann H; Maison RM; Hartwig A; Masleša-Galić S; Bowen RA; Horwitz MA
Microbiol Spectr; 2023 Mar; 11(2):e0503522. PubMed ID: 36916971
[TBL] [Abstract][Full Text] [Related]
34. Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2.
Park HS; Matsuoka Y; Luongo C; Yang L; Santos C; Liu X; Ahlers LRH; Moore IN; Afroz S; Johnson RF; Lafont BAP; Dorward DW; Fischer ER; Martens C; Samal SK; Munir S; Buchholz UJ; Le Nouën C
NPJ Vaccines; 2022 Jun; 7(1):72. PubMed ID: 35764659
[TBL] [Abstract][Full Text] [Related]
35. Full protection from SARS-CoV-2 brain infection and damage in susceptible transgenic mice conferred by MVA-CoV2-S vaccine candidate.
Villadiego J; García-Arriaza J; Ramírez-Lorca R; García-Swinburn R; Cabello-Rivera D; Rosales-Nieves AE; Álvarez-Vergara MI; Cala-Fernández F; García-Roldán E; López-Ogáyar JL; Zamora C; Astorgano D; Albericio G; Pérez P; Muñoz-Cabello AM; Pascual A; Esteban M; López-Barneo J; Toledo-Aral JJ
Nat Neurosci; 2023 Feb; 26(2):226-238. PubMed ID: 36624276
[TBL] [Abstract][Full Text] [Related]
36. Absence of Vaccine-enhanced Disease With Unexpected Positive Protection Against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by Inactivated Vaccine Given Within 3 Days of Virus Challenge in Syrian Hamster Model.
Li C; Chen YX; Liu FF; Lee AC; Zhao Y; Ye ZH; Cai JP; Chu H; Zhang RQ; Chan KH; Chiu KH; Lung DC; Sridhar S; Hung IF; To KK; Zhang AJ; Chan JF; Yuen KY
Clin Infect Dis; 2021 Aug; 73(3):e719-e734. PubMed ID: 33515458
[TBL] [Abstract][Full Text] [Related]
37. A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge.
Henning L; Endt K; Steigerwald R; Anderson M; Volkmann A
Front Immunol; 2020; 11():598847. PubMed ID: 33542715
[TBL] [Abstract][Full Text] [Related]
38. Synthetic multiantigen MVA vaccine COH04S1 and variant-specific derivatives protect Syrian hamsters from SARS-CoV-2 Omicron subvariants.
Wussow F; Kha M; Kim T; Ly M; Yll-Pico M; Kar S; Lewis MG; Chiuppesi F; Diamond DJ
NPJ Vaccines; 2023 Mar; 8(1):41. PubMed ID: 36928589
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Immunogenicity and Clinical Protection of SARS-CoV-2 S1 and N Antigens in Syrian Golden Hamster.
Niu Z; Li X; Gao Y; Wang L; Fan S; Xu X; Jiang G; Cui P; Li D; Liao Y; Yu L; Zhao H; Zhang Y; Li Q
Vaccines (Basel); 2022 Nov; 10(12):. PubMed ID: 36560406
[TBL] [Abstract][Full Text] [Related]
40. Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus Platform.
Chiuppesi F; Salazar MD; Contreras H; Nguyen V; Martinez J; Park S; Nguyen J; Kha M; Iniguez A; Zhou Q; Kaltcheva T; Levytskyy R; Ebelt N; Kang T; Wu X; Rogers T; Manuel E; Shostak Y; Diamond D; Wussow F
Res Sq; 2020 Jul; ():. PubMed ID: 32702732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
